tiprankstipranks
Ironwood Pharma (IRWD)
NASDAQ:IRWD

Ironwood Pharma (IRWD) Financial Statements

228 Followers

Ironwood Pharma Financial Overview

Ironwood Pharma's market cap is currently ―. The company's EPS TTM is $-6.788; its P/E ratio is -0.96; Ironwood Pharma is scheduled to report earnings on August 1, 2024, and the estimated EPS forecast is $0.16. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue$ 74.88M$ 117.55M$ 107.38M$ 104.06M-
Gross Profit$ 74.88M$ 123.17M$ 1.21B$ 104.06M-
EBIT$ 12.63M$ 37.66M$ -1.07B$ 66.26M-
EBITDA$ 13.73M$ 38.76M$ -1.07B$ 66.95M-
Net Income Common Stockholders$ -4.16M$ -1.09M$ -1.06B$ 45.76M-
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 121.54M$ 92.15M$ 176.11M$ 741.59M$ 657.50M
Total Assets$ 438.82M$ 471.07M$ 603.22M$ 1.16B$ 1.10B
Total Debt$ 690.42M$ 715.54M$ 815.75M$ 415.84M$ 415.92M
Net Debt$ 568.88M$ 623.38M$ 639.64M$ -325.75M$ -241.59M
Total Liabilities$ 769.34M$ 817.37M$ 950.00M$ 448.43M$ 1.10B
Stockholders Equity$ -330.52M$ -346.30M$ -345.70M$ 706.85M$ 652.38M
Cash Flow-
Free Cash Flow$ 44.92M$ 35.62M$ 34.96M$ 80.16M$ 79.21M
Operating Cash Flow$ 44.98M$ 35.83M$ 34.96M$ 80.17M$ 79.18M
Investing Cash Flow$ -68.00K$ -4.19M$ -999.49M$ -13.00K$ 27.00K
Financing Cash Flow$ -15.55M$ -50.90M$ 399.07M$ 3.98M$ 2.81M
Currency in USD

Ironwood Pharma Earnings and Revenue History

Ironwood Pharma Debt to Assets

Ironwood Pharma Cash Flow

Ironwood Pharma Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis